Life ScienceCompany
Lexicon Pharmaceuticals M&A Summary
Lexicon Pharmaceuticals has acquired 1 company. It has also divested 1 asset.
Lexicon Pharmaceuticals’ largest acquisition to date was in 2010, when it acquired Symphony Icon for $90M. It’s largest disclosed sale occurred in 2020, when it sold Lexicon Pharmaceuticals - XERMELO to TerSera Therapeutics for $159M. Lexicon Pharmaceuticals has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).
Lexicon Pharmaceuticals Business Overview
Where is Lexicon Pharmaceuticals headquartered?
Lexicon Pharmaceuticals is headquartered in The Woodlands, Texas.
What is Lexicon Pharmaceuticals’ revenue?
Lexicon Pharmaceuticals disclosed revenue of 1M USD for 2023 and 24M USD for 2020.
How many employees does Lexicon Pharmaceuticals have?
Lexicon Pharmaceuticals has 285 employees.
What sector is Lexicon Pharmaceuticals in?
Lexicon Pharmaceuticals is a life science company.
When was Lexicon Pharmaceuticals founded?
Lexicon Pharmaceuticals was founded in 1995.
M&A Summary
-
M&A Total Activity2
- M&A Buy Activity1
- M&A Sell Activity1
- Total Sectors Invested 1
- Total Countries Invested 1
- M&A Buy/Sell Connections 1
Unlimited Searches
